Nexavar Tablet, Film Coated
Product Images NDC 50419-488

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Nexavar (NDC 50419-488). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bayer Healthcare Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

7c4c29f2 1bbf 4eb3 8685 A44154d1c198 00

FDA Label Image

Structural Formula (Image 01)

Chemical structure diagram of sorafenib tosylate, the active ingredient in Nexavar 200 mg oral film-coated tablets, showing its molecular arrangement including trifluoromethyl, chloro, amide, ether, and sulfonic acid functional groups.*

FDA Label Image

Fig 1 (Image 02)

A Kaplan-Meier survival curve graph depicting time versus probability of survival for patients in a clinical study. The graph shows two distinct survival lines comparing sorafenib and placebo groups over a period of up to 12 months, illustrating a difference in overall survival outcomes.*

FDA Label Image

Fig 2 (Image 03)

A Kaplan-Meier survival curve showing progression-free survival probability (%) over days from randomization for Nexavar (sorafenib) and placebo groups. The chart compares Nexavar (black line, median 167 days) to placebo (gray line, median 84 days) for 384 and 385 patients respectively, indicating higher survival probability with Nexavar treatment.*

FDA Label Image

Fig 3 (Image 04)

A Kaplan-Meier plot comparing progression-free survival over time in months between Nexavar (sorafenib) and placebo groups. The vertical axis shows the proportion of progression-free survival, and the horizontal axis indicates time up to 30 months. The plot includes two lines: a solid black line for Nexavar (N=207) and a dashed gray line for placebo (N=210), with patient counts at risk listed below the timeline.*

FDA Label Image

Label

Nexavar 200 mg film-coated tablets label, containing sorafenib as the active ingredient. The label indicates a package size of 120 tablets. It is manufactured for Bayer HealthCare Pharmaceuticals Inc., Whippany, NJ, and produced in Germany. The label includes the NDC number 50419-488-58 and space for batch number and expiration date.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.